BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32597707)

  • 1. Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia.
    Pataia V; McIlvride S; Papacleovoulou G; Ovadia C; McDonald JAK; Wahlström A; Jansen E; Adorini L; Shapiro D; Marchesi JR; Marschall HU; Williamson C
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G197-G211. PubMed ID: 32597707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes.
    McIlvride S; Nikolova V; Fan HM; McDonald JAK; Wahlström A; Bellafante E; Jansen E; Adorini L; Shapiro D; Jones P; Marchesi JR; Marschall HU; Williamson C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E399-E410. PubMed ID: 31237448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of obeticholic acid on lipopolysaccharide-induced disorder of maternal bile acid metabolism in pregnant mice.
    Zhang C; Gan Y; Lv JW; Qin MQ; Hu WR; Liu ZB; Ma L; Song BD; Li J; Jiang WY; Wang JQ; Wang H; Xu DX
    Int Immunopharmacol; 2020 Jun; 83():106442. PubMed ID: 32248018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.
    Abu-Hayyeh S; Papacleovoulou G; Lövgren-Sandblom A; Tahir M; Oduwole O; Jamaludin NA; Ravat S; Nikolova V; Chambers J; Selden C; Rees M; Marschall HU; Parker MG; Williamson C
    Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid.
    de Haan LR; Verheij J; van Golen RF; Horneffer-van der Sluis V; Lewis MR; Beuers UHW; van Gulik TM; Olde Damink SWM; Schaap FG; Heger M; Olthof PB
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33578971
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models.
    Zhang Y; LaCerte C; Kansra S; Jackson JP; Brouwer KR; Edwards JE
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice.
    Chen W; Gao XX; Ma L; Liu ZB; Li L; Wang H; Gao L; Xu DX; Chen YH
    Oxid Med Cell Longev; 2019; 2019():7419249. PubMed ID: 31827696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
    Ren L; Song Q; Liu Y; Zhang L; Hao Z; Feng W
    Biochem Biophys Res Commun; 2019 Nov; 520(1):67-72. PubMed ID: 31575408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
    Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta--a study on maternal cholestasis model.
    Wu WB; Xu YY; Cheng WW; Wang YX; Liu Y; Huang D; Zhang HJ
    Placenta; 2015 May; 36(5):545-51. PubMed ID: 25747729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
    PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis.
    Kjærgaard K; Frisch K; Sørensen M; Munk OL; Hofmann AF; Horsager J; Schacht AC; Erickson M; Shapiro D; Keiding S
    J Hepatol; 2021 Jan; 74(1):58-65. PubMed ID: 32717289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
    Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obeticholic acid alleviates intrauterine growth restriction induced by di-ethyl-hexyl phthalate in pregnant female mice by improving bile acid disorder.
    Zhao F; Zhang L; Qu M; Ye L; Zhang J; Yu Y; Huang Q; Zhang C; Wang J
    Environ Sci Pollut Res Int; 2023 Nov; 30(51):110956-110969. PubMed ID: 37798517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.
    Borges Manna L; Papacleovoulou G; Flaviani F; Pataia V; Qadri A; Abu-Hayyeh S; McIlvride S; Jansen E; Dixon P; Chambers J; Vazquez-Lopez M; Wahlström A; Kitaba N; Marschall HU; Godfrey KM; Lillycrop K; Williamson C
    Sci Rep; 2020 Jun; 10(1):10361. PubMed ID: 32587408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
    Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S
    J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis.
    van Golen RF; Olthof PB; Lionarons DA; Reiniers MJ; Alles LK; Uz Z; de Haan L; Ergin B; de Waart DR; Maas A; Verheij J; Jansen PL; Damink SWO; Schaap FG; van Gulik TM; Heger M
    Sci Rep; 2018 Nov; 8(1):16529. PubMed ID: 30409980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
    Carino A; Biagioli M; Marchianò S; Fiorucci C; Bordoni M; Roselli R; Di Giorgio C; Baldoni M; Ricci P; Monti MC; Morretta E; Zampella A; Distrutti E; Fiorucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158733. PubMed ID: 32371093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury.
    Lu Q; Zhu Y; Wang C; Zhang R; Miao Y; Chai Y; Jiang Z; Yu Q
    Life Sci; 2024 Jan; 337():122355. PubMed ID: 38104861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.